Network Bio
New York
About Network Bio
Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $19.5M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: network.bio
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biopharma, Life Science, Medical
Canonical: https://fsome.com/organization/network-bio-81564 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.